Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
BiSiChem Logo
BiSiChem Growth Score
58
CB Rank
103601
Heat Score
68
BiSiChem is a biotechnology company that focuses on the drug discovery and development field.
Founded
obfuscation
PrivateSeries B Bundangdong, Kyonggi-do, South Korea11-50 www.bisichem.com/
Biopharma
Biotechnology
Life Science
Overview

BiSiChem
Total Funding
obfuscation
Growth Score
58
Heat Score
68

Total Funding
obfuscation
obfuscation
Series B raised
obfuscation
Growth Score58
-2 pts
in past quarter
Heat Score 68
-6 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About BiSiChem

CB Rank
103601
BiSiChem is a biotechnology company that focuses on the drug discovery and development field.
Founded
obfuscation
PrivateSeries B Bundangdong, Kyonggi-do, South Korea11-50 www.bisichem.com/
Biopharma
Biotechnology
Life Science

Funding Rounds

Series B
OBF
in
obfuscation
Series A
OBF
in
obfuscation

Details

Legal Name ㈜비씨켐
Also Known As BSC, 비씨켐
Operating Status Active
Company Type For Profit
Phone Number 82-31-698-3772
Contact Email bsc@bisichem.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Targeted Small Molecule Drugs
Small molecule drugs designed to selectively target specific biological pathways, developed as first-in-class or second-generation therapies.
Preclinical Candidate Selection Services
Services involving the selection of drug candidates through target identification, medicinal chemistry, biology, and drug metabolism and pharmacokinetics (DMPK) expertise.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - BiSiChem Logo
Series B - BiSiChem
3
obfuscation
— Series B
obfuscation
Series B - BiSiChem Logo
Series B - BiSiChem
3
obfuscation
— Series B
obfuscation
Series B - BiSiChem Logo
Series B - BiSiChem
3
obfuscation
— Series B
obfuscation
Series B - BiSiChem Logo
Series B - BiSiChem
3
obfuscation
— Series B
obfuscation
Series B - BiSiChem Logo
Series B - BiSiChem
3
obfuscation
— Series B

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - BiSiChem Logo
Series B - BiSiChem
3
obfuscation
— Series B
obfuscation
Series B - BiSiChem Logo
Series B - BiSiChem
3
obfuscation
— Series B
obfuscation
Series B - BiSiChem Logo
Series B - BiSiChem
3
obfuscation
— Series B
obfuscation
Series B - BiSiChem Logo
Series B - BiSiChem
3
obfuscation
— Series B
obfuscation
Series B - BiSiChem Logo
Series B - BiSiChem
3
obfuscation
— Series B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
DS Asset Management Logo
DS Asset Management
—
Series B - BiSiChem Logo
Series B - BiSiChem
—
DS Asset Management Logo
DS Asset Management
—
Series B - BiSiChem Logo
Series B - BiSiChem
—
DS Asset Management Logo
DS Asset Management
—
Series B - BiSiChem Logo
Series B - BiSiChem
—
DS Asset Management Logo
DS Asset Management
—
Series B - BiSiChem Logo
Series B - BiSiChem
—
DS Asset Management Logo
DS Asset Management
—
Series B - BiSiChem Logo
Series B - BiSiChem
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50
News

News and Press

News•Mar 10, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

64

Active Website Tech Count

4BiSiChem is actively using 4 technologies for its website, according to BuiltWith. These include CommonCrawl Top 10m, CodeMirror, and  Froala Editor.

Total IP

9The intellectual property of BiSiChem includes 9 registered patents primarily in the 'Organic Chemistry' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is BiSiChem's headquarters? BiSiChem is located in Bundangdong, Kyonggi-do, South Korea.Who invested in BiSiChem? BiSiChem has 4 investors including DS Asset Management and  Soo Investment Capital.When was the last funding round for BiSiChem? BiSiChem closed its last funding round on
obfuscation
from a Series B round.Who are BiSiChem's competitors? Alternatives and possible competitors to BiSiChem may include Insilico Medicine, WuXi AppTec, and  Nimbus Therapeutics.How much funding has BiSiChem raised to date? BiSiChem has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3120884 1)
|